Rep. Julie Johnson Sells Off Shares of Agilent Technologies, Inc. (NYSE:A)

Representative Julie Johnson (D-Texas) recently sold shares of Agilent Technologies, Inc. NYSE: A. In a filing disclosed on April 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Agilent Technologies stock on March 3rd. The trade occurred in the Representative's "MERRILL LYNCH LONG TERM GROWTH" account.

Representative Julie Johnson also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Capital One Financial NYSE: COF on 3/21/2025.
• Sold $1,001 - $15,000 in shares of Accenture NYSE: ACN on 3/19/2025.
• Purchased $1,001 - $15,000 in shares of The Cigna Group NYSE: CI on 3/19/2025.
• Sold $1,001 - $15,000 in shares of Accenture NYSE: ACN on 3/14/2025.
• Sold $1,001 - $15,000 in shares of Accenture NYSE: ACN on 3/12/2025.
• Purchased $1,001 - $15,000 in shares of 3M NYSE: MMM on 3/12/2025.
• Sold $1,001 - $15,000 in shares of Webster Financial NYSE: WBS on 3/11/2025.
• Sold $1,001 - $15,000 in shares of Sonos NASDAQ: SONO on 3/11/2025.
• Sold $1,001 - $15,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 3/11/2025.
• Sold $1,001 - $15,000 in shares of Teradyne NASDAQ: TER on 3/3/2025.

Agilent Technologies Stock Up 2.3 %

NYSE A traded up $2.29 on Tuesday, reaching $102.55. The company had a trading volume of 977,855 shares, compared to its average volume of 1,857,729. The company's fifty day moving average is $118.79 and its 200-day moving average is $132.00. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $155.35. The firm has a market capitalization of $29.24 billion, a price-to-earnings ratio of 23.55, a price-to-earnings-growth ratio of 2.89 and a beta of 1.19. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The company had revenue of $1.68 billion during the quarter, compared to analysts' expectations of $1.67 billion. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.54 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.97%. Agilent Technologies's payout ratio is 22.76%.

Insiders Place Their Bets

In related news, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares of the company's stock, valued at $4,161,931.02. This trade represents a 4.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares of the company's stock, valued at $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Institutional Investors Weigh In On Agilent Technologies

A number of hedge funds and other institutional investors have recently bought and sold shares of A. CKW Financial Group boosted its position in Agilent Technologies by 114.9% during the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after buying an additional 100 shares during the period. Global X Japan Co. Ltd. lifted its holdings in shares of Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after purchasing an additional 116 shares during the period. Redwood Park Advisors LLC bought a new stake in shares of Agilent Technologies in the fourth quarter worth $27,000. Lee Danner & Bass Inc. acquired a new stake in Agilent Technologies in the fourth quarter valued at $29,000. Finally, Whipplewood Advisors LLC raised its position in Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after purchasing an additional 186 shares during the last quarter.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Barclays lowered their price target on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Robert W. Baird lowered their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a report on Thursday, February 27th. StockNews.com upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. Jefferies Financial Group lowered their price objective on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday. Finally, TD Cowen upped their price target on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research note on Thursday, April 10th. Seven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $143.00.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.